secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001628280-24-020128
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem reports record Q1 net sales of $239.7M, adjusted EBITDA up 8%
---------------------------------------------------------------------

- Net sales $239.7M (+3.1% YoY), adjusted EBITDA $60.9M (+8.0% YoY), both all-time records.
- GAAP EPS $0.89 vs $0.70; adjusted EPS $1.03 vs $0.94 in prior-year quarter.
- Human Nutrition & Health segment sales $152.7M (+15.1%), earnings $33.3M (+80.4%).
- Cash from operations $33.4M; free cash flow $26.8M for Q1 2024.
- VitaCholine became Proud Partner of New York Jets, first sponsorship in nutritional ingredient category.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000162828024020128/0001628280-24-020128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000162828024020128/bcpc-20240503.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-020128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer